Clinical Trial Update: AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study) [NA]

View source ↗

Summary

The RESTOR-1 trial evaluating the AngioSafe Peripheral CTO Crossing System in peripheral arterial disease and occlusion has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease
• Peripheral Artery Occlusion

Drugs mentioned

• AngioSafe Peripheral CTO Crossing System

Snippet

Sponsor: AngioSafe, Inc. | Conditions: Peripheral Artery Occlusion, Peripheral Arterial Disease | NA | Status: COMPLETED | Results posted: 2026-02-12